Ambiguities in the preclinical quality assessment of microparticulate vaccines.
about
Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy.Microparticles as vaccine adjuvants and delivery systems.Nanoparticles and microparticles as vaccine-delivery systems.Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy.Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis.Formulation and characterization of immunoreactive tetanus toxoid biodegradable polymer particles.Humoral and cell-mediated immune-responses after administration of a single-shot recombinant hepatitis B surface antigen vaccine formulated with cationic poly(l-lactide) microspheres.
P2860
Q34775944-E33A834B-B167-4848-BC01-0B4D0AD9A3C7Q35192199-6DC3563B-5722-49E3-86DF-9F197BC79731Q36968297-EA9B6B14-2E1C-4713-86AB-0D42A66EFFECQ37785952-61D89CA3-33D3-43E2-A732-1623F521C606Q38341522-55F624B9-2BF4-4802-990B-2B282BD1AC30Q39640571-92E18285-84C7-4D0C-BE6C-86F001AB7077Q43411758-6043FE80-9D75-49CA-B19C-62BEF4C8B50EQ45803020-9F219A13-DB0C-4BBE-9945-AFCAE3F0BE20
P2860
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
@ast
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
@en
type
label
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
@ast
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
@en
prefLabel
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
@ast
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
@en
P2093
P1476
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
@en
P2093
P304
P356
10.1016/S0167-7799(00)01437-2
P577
2000-05-01T00:00:00Z